Jacob Klein

Hi-IMPAcTB is an ambitious endeavor bringing together a team of international, interdisciplinary researchers to improve our understanding of host-pathogen interactions in the context of tuberculosis (TB). Funded by a multi-center contract from the NIH, the long-term goal of the consortium is to enable principled vaccine and diagnostics design by improving our understanding of the protective versus non-protective immunological host response to infection with TB’s causal agent the bacterium ...